Literature DB >> 28870287

Stress responsive miR-31 is a major modulator of mouse intestinal stem cells during regeneration and tumorigenesis.

Yuhua Tian1, Xianghui Ma1, Cong Lv1, Xiaole Sheng1, Xiang Li1, Ran Zhao1, Yongli Song1, Thomas Andl2, Maksim V Plikus3, Jinyue Sun4, Fazheng Ren1, Jianwei Shuai5, Christopher J Lengner6,7, Wei Cui8, Zhengquan Yu1.   

Abstract

Intestinal regeneration and tumorigenesis are believed to be driven by intestinal stem cells (ISCs). Elucidating mechanisms underlying ISC activation during regeneration and tumorigenesis can help uncover the underlying principles of intestinal homeostasis and disease including colorectal cancer. Here we show that miR-31 drives ISC proliferation, and protects ISCs against apoptosis, both during homeostasis and regeneration in response to ionizing radiation injury. Furthermore, miR-31 has oncogenic properties, promoting intestinal tumorigenesis. Mechanistically, miR-31 acts to balance input from Wnt, BMP, TGFβ signals to coordinate control of intestinal homeostasis, regeneration and tumorigenesis. We further find that miR-31 is regulated by the STAT3 signaling pathway in response to radiation injury. These findings identify miR-31 as a critical modulator of ISC biology, and a potential therapeutic target for a broad range of intestinal regenerative disorders and cancers.

Entities:  

Keywords:  BMP; Wnt; colorectal cancer; developmental biology; intestinal stem cell; miR-31; mouse; regeneration; stem cells

Mesh:

Substances:

Year:  2017        PMID: 28870287      PMCID: PMC5584991          DOI: 10.7554/eLife.29538

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.140


  62 in total

1.  Bmi1 is expressed in vivo in intestinal stem cells.

Authors:  Eugenio Sangiorgi; Mario R Capecchi
Journal:  Nat Genet       Date:  2008-06-08       Impact factor: 38.330

Review 2.  MicroRNAs in stress signaling and human disease.

Authors:  Joshua T Mendell; Eric N Olson
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

3.  Beta-catenin mutations in cell lines established from human colorectal cancers.

Authors:  M Ilyas; I P Tomlinson; A Rowan; M Pignatelli; W F Bodmer
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

4.  Mouse Label-Retaining Cells Are Molecularly and Functionally Distinct From Reserve Intestinal Stem Cells.

Authors:  Ning Li; Angela Nakauka-Ddamba; John Tobias; Shane T Jensen; Christopher J Lengner
Journal:  Gastroenterology       Date:  2016-05-27       Impact factor: 22.682

5.  MicroRNAs control intestinal epithelial differentiation, architecture, and barrier function.

Authors:  Lindsay B McKenna; Jonathan Schug; Anastassios Vourekas; Jaime B McKenna; Nuria C Bramswig; Joshua R Friedman; Klaus H Kaestner
Journal:  Gastroenterology       Date:  2010-07-24       Impact factor: 22.682

6.  Transforming Growth Factor β Signaling in Colorectal Cancer Cells With Microsatellite Instability Despite Biallelic Mutations in TGFBR2.

Authors:  Noel F C C de Miranda; Maarten van Dinther; Brendy E W M van den Akker; Tom van Wezel; Peter ten Dijke; Hans Morreau
Journal:  Gastroenterology       Date:  2015-02-28       Impact factor: 22.682

7.  Functional intestinal stem cells after Paneth cell ablation induced by the loss of transcription factor Math1 (Atoh1).

Authors:  Aurélie Durand; Bridgitte Donahue; Grégory Peignon; Franck Letourneur; Nicolas Cagnard; Christian Slomianny; Christine Perret; Noah F Shroyer; Béatrice Romagnolo
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-14       Impact factor: 11.205

Review 8.  MicroRNAs: key regulators of stem cells.

Authors:  Vamsi K Gangaraju; Haifan Lin
Journal:  Nat Rev Mol Cell Biol       Date:  2009-02       Impact factor: 94.444

9.  The AOM/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studies.

Authors:  Mariangela De Robertis; Emanuela Massi; Maria Luana Poeta; Simone Carotti; Sergio Morini; Loredana Cecchetelli; Emanuela Signori; Vito Michele Fazio
Journal:  J Carcinog       Date:  2011-03-24

10.  Intestinal crypt homeostasis revealed at single-stem-cell level by in vivo live imaging.

Authors:  Laila Ritsma; Saskia I J Ellenbroek; Anoek Zomer; Hugo J Snippert; Frederic J de Sauvage; Benjamin D Simons; Hans Clevers; Jacco van Rheenen
Journal:  Nature       Date:  2014-02-16       Impact factor: 49.962

View more
  23 in total

Review 1.  Epigenetic regulation of intestinal stem cell differentiation.

Authors:  Michael P Verzi; Ramesh A Shivdasani
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-07-06       Impact factor: 4.052

2.  Secreted stromal protein ISLR promotes intestinal regeneration by suppressing epithelial Hippo signaling.

Authors:  Jiuzhi Xu; Yang Tang; Xiaole Sheng; Yuhua Tian; Min Deng; Sujuan Du; Cong Lv; Guili Li; Yuwei Pan; Yongli Song; Pengbo Lou; Yongting Luo; Yuan Li; Bing Zhang; Yanmei Chen; Zhanju Liu; Yingzi Cong; Maksim V Plikus; Qingyong Meng; Zhaocai Zhou; Zhengquan Yu
Journal:  EMBO J       Date:  2020-03-04       Impact factor: 11.598

3.  Colonic epithelial miR-31 associates with the development of Crohn's phenotypes.

Authors:  Benjamin P Keith; Jasmine B Barrow; Takahiko Toyonaga; Nevzat Kazgan; Michelle Hoffner O'Connor; Neil D Shah; Matthew S Schaner; Elisabeth A Wolber; Omar K Trad; Greg R Gipson; Wendy A Pitman; Matthew Kanke; Shruti J Saxena; Nicole Chaumont; Timothy S Sadiq; Mark J Koruda; Paul A Cotney; Nancy Allbritton; Dimitri G Trembath; Francisco Sylvester; Terrence S Furey; Praveen Sethupathy; Shehzad Z Sheikh
Journal:  JCI Insight       Date:  2018-10-04

4.  MiR-31 Mediates Inflammatory Signaling to Promote Re-Epithelialization during Skin Wound Healing.

Authors:  Jianyun Shi; Xianghui Ma; Yang Su; Yongli Song; Yuhua Tian; Shukai Yuan; Xiuqing Zhang; Dong Yang; Hao Zhang; Jianwei Shuai; Wei Cui; Fazheng Ren; Maksim V Plikus; Yaoxing Chen; Jie Luo; Zhengquan Yu
Journal:  J Invest Dermatol       Date:  2018-03-30       Impact factor: 8.551

5.  EphB2 stem-related and EphA2 progression-related miRNA-based networks in progressive stages of CRC evolution: clinical significance and potential miRNA drivers.

Authors:  Mariangela De Robertis; Tommaso Mazza; Caterina Fusilli; Luisa Loiacono; Maria Luana Poeta; Massimo Sanchez; Emanuela Massi; Giuseppe Lamorte; Maria Grazia Diodoro; Edoardo Pescarmona; Emanuela Signori; Graziano Pesole; Angelo Luigi Vescovi; Jesus Garcia-Foncillas; Vito Michele Fazio
Journal:  Mol Cancer       Date:  2018-11-30       Impact factor: 27.401

6.  Long noncoding RNA MIR31HG is a bona fide prognostic marker with colorectal cancer cell-intrinsic properties.

Authors:  Peter W Eide; Ina A Eilertsen; Anita Sveen; Ragnhild A Lothe
Journal:  Int J Cancer       Date:  2019-01-12       Impact factor: 7.396

7.  Polydatin Increases Radiosensitivity by Inducing Apoptosis of Stem Cells in Colorectal Cancer.

Authors:  Qiu Chen; Ya-Nan Zeng; Ke Zhang; Ying Zhao; Yong-You Wu; Gen Li; Hui-Ying Cheng; Meng Zhang; Feng Lai; Jin-Bing Wang; Feng-Mei Cui
Journal:  Int J Biol Sci       Date:  2019-01-01       Impact factor: 6.580

8.  Salivary MicroRNA for Diagnosis of Cancer and Systemic Diseases: A Systematic Review.

Authors:  Giacomo Setti; Margherita E Pezzi; Maria Vittoria Viani; Thelma A Pertinhez; Diana Cassi; Cristina Magnoni; Pierantonio Bellini; Antonino Musolino; Paolo Vescovi; Marco Meleti
Journal:  Int J Mol Sci       Date:  2020-01-30       Impact factor: 5.923

9.  MiR-20b Down-Regulates Intestinal Ferroportin Expression In Vitro and In Vivo.

Authors:  Shuxia Jiang; Xi Fang; Mingni Liu; Yingdong Ni; Wenqiang Ma; Ruqian Zhao
Journal:  Cells       Date:  2019-09-24       Impact factor: 6.600

10.  PEX5, a novel target of microRNA-31-5p, increases radioresistance in hepatocellular carcinoma by activating Wnt/β-catenin signaling and homologous recombination.

Authors:  Jie Wen; Kai Xiong; Abudureyimujiang Aili; Hao Wang; Yuequan Zhu; Zhengquan Yu; Xueyan Yao; Ping Jiang; Lixiang Xue; Junjie Wang
Journal:  Theranostics       Date:  2020-04-06       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.